Henan Lingrui Pharmaceutical (600285.SS) Earnings Analysis
Henan Lingrui Pharmaceutical (600285.SS) has no confirmed upcoming earnings date. Trailing P/E 16.27.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600285.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600285.SS. This page updates as the calendar is published.
600285.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-29 | 0.311 CNY | n/a | n/a | n/a |
| 2025-06-30 | 0.4538 CNY | n/a | n/a | n/a |
| 2025-04-25 | 0.382 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.2628 CNY | n/a | n/a | n/a |
| 2024-08-12 | 0.392 CNY | n/a | n/a | n/a |
600285.SS valuation and analyst view
| Trailing P/E | 16.27 |
|---|---|
| Trailing EPS | 1.393 CNY |
| Price / book | 3.51 |
| Dividend yield | 4.87% |
| Market cap | 12.71B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Henan Lingrui Pharmaceutical (600285.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600285.SS. This page updates as the calendar is published.
Did 600285.SS beat earnings last quarter?
Consensus estimate data was not available for 600285.SS's 2025-09-29 report.
What is 600285.SS's current P/E ratio and EPS?
600285.SS trades at a trailing P/E of 16.27 on trailing EPS of 1.3933271207871794 CNY.
What do analysts rate 600285.SS?
600285.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.